1-7 of 7
John Leighton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer

Sonia Singh, Adnan A. Jaigirdar, Flora Mulkey, Joyce Cheng, Salaheldin S. Hamed, Yangbing Li, Jiang Liu, Hong Zhao, Anwar Goheer, Whitney S. Helms, Xing Wang, Rajiv Agarwal, Rajan Pragani, Kwadwo Korsah, Shenghui Tang, John Leighton, Atiqur Rahman, Julia A. Beaver, Richard Pazdur, Marc R. Theoret, Harpreet Singh
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (9): 2378–2382.
https://doi.org/10.1158/1078-0432.CCR-20-3901
Published: 01 May 2021
View article titled, FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
Open the PDF for FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary

Yangmin M. Ning, William Pierce, V. Ellen Maher, Stella Karuri, Sheng-Hui Tang, Haw-Jyh Chiu, Todd Palmby, Jeanne Fourie Zirkelbach, Dhananjay Marathe, Nitin Mehrotra, Qi Liu, Debasis Ghosh, Christy L. Cottrell, John Leighton, Rajeshwari Sridhara, Amna Ibrahim, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (22): 6067–6073.
https://doi.org/10.1158/1078-0432.CCR-13-1763
Published: 14 November 2013
View article titled, Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary
Open the PDF for Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary in another window
Journal Articles

Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies

Robert J. Lechleider, Edvardas Kaminskas, Xiaoping Jiang, Robeena Aziz, Julie Bullock, Ravindra Kasliwal, Ravi Harapanhalli, Sarah Pope, Rajeshwari Sridhara, John Leighton, Brian Booth, Ramzi Dagher, Robert Justice, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (14): 4378–4384.
https://doi.org/10.1158/1078-0432.CCR-08-0015
Published: 15 July 2008
View article titled, Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies
Open the PDF for Ixabepilone in Combination with Capecitabine and as Monotherapy for Treatment of Advanced Breast Cancer Refractory to Previous Chemotherapies in another window
Journal Articles

Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen

John R. Johnson, Martin Cohen, Rajeshwari Sridhara, Yeh-Fong Chen, Gene M. Williams, John Duan, Jogarao Gobburu, Brian Booth, Kimberly Benson, John Leighton, Li Shan Hsieh, Nallalerumal Chidambaram, Paul Zimmerman, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6414–6421.
https://doi.org/10.1158/1078-0432.CCR-05-0790
Published: 15 September 2005
View article titled, Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen
Open the PDF for Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen in another window
Journal Articles

Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma

Peter F. Bross, Robert Kane, Ann T. Farrell, Sophia Abraham, Kimberly Benson, Margaret E. Brower, Sean Bradley, Jogarao V. Gobburu, Anwar Goheer, Shwu-Luan Lee, John Leighton, Cheng Yi Liang, Richard T. Lostritto, William D. McGuinn, David E. Morse, Atiqur Rahman, Lilliam A. Rosario, S. Leigh Verbois, Grant Williams, Yong-Cheng Wang, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (12): 3954–3964.
https://doi.org/10.1158/1078-0432.CCR-03-0781
Published: 24 June 2004
View article titled, Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
Open the PDF for Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma in another window
Journal Articles

Approval Summary for Zoledronic Acid for Treatment of Multiple Myeloma and Cancer Bone Metastases

Amna Ibrahim, Nancy Scher, Grant Williams, Rajeshwari Sridhara, Ning Li, Gang Chen, John Leighton, Brian Booth, Jogarao V. S. Gobburu, Atiqur Rahman, Yung Hsieh, Rebecca Wood, Debra Vause, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (7): 2394–2399.
Published: 01 July 2003
View article titled, Approval Summary for Zoledronic Acid for Treatment of Multiple Myeloma and Cancer Bone Metastases
Open the PDF for Approval Summary for Zoledronic Acid for Treatment of Multiple Myeloma and Cancer Bone Metastases in another window
Journal Articles

Approval Summary for Imatinib Mesylate Capsules in the Treatment of Chronic Myelogenous Leukemia

Martin H. Cohen, Grant Williams, John R. Johnson, John Duan, Jogarao Gobburu, Atiqur Rahman, Kimberly Benson, John Leighton, Sung K. Kim, Rebecca Wood, Mark Rothmann, Gang Chen, Khin Maung U, Ann M. Staten, Richard Pazdur
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 935–942.
Published: 01 May 2002
View article titled, Approval Summary for Imatinib Mesylate Capsules in the Treatment of Chronic Myelogenous Leukemia
Open the PDF for Approval Summary for Imatinib Mesylate Capsules in the Treatment of Chronic Myelogenous Leukemia in another window